Clinical Trial

Clinical Decision-Making During FEES: The Impact of Residue Amount and Location

Study acronym: IRAL
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
In this study, the investigator aims to identify the threshold of food residue visualized in the throat during a FEES (fiberoptic endoscopic evaluation of swallowing) that speech-language pathologists allow before restricting a patient from eating. 60 speech-language pathologists will be required to participate, with half of them watching a pre-recorded video detailing current research about residue in the throat of pharynx. The group watching the video will then re-score their images. This investigates the impact of education on clinical decision-making. Finally, 8 clinicians will meet with the researcher individually to share their clinical decision-making rationale. With this information, the researcher hopes to identify a patient population who is at risk for diet restrictions in order to encourage speech-language pathologists to extend the swallow study and trial more compensatory strategies before restricting the patient's diet.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-28.
Trial Details
NCT Number NCT07278076
Lead Sponsor Rush University Medical Center
Conditions Decision Making
Enrollment 60 participants
Start Date 2026-11-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-05-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-20